Psoriasis during therapy with olanzapine

European Journal of Dermatology

Volumn 13, Issue 4, 2003, Pages 404-405

  Latini, Alessandra ^a   Carducci, Massimo ^a  

^a Polo Dermatologico S Gallicano   (Italy)

Author keywords

Olanzapine; Psoriasis; Psychosis; Side effects

Indexed keywords

AMITRIPTYLINE PLUS PERPHENAZINE; CLOBETASOL PROPIONATE; CYCLOSPORIN A; OLANZAPINE; RISPERIDONE; SALICYLIC ACID DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG SAFETY; HUMAN; MALE; PSORIASIS; RELAPSE; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PIRENZEPINE; PSORIASIS; SCHIZOPHRENIA;

EID: 0043162022     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wolf R, Ruocco V. Triggered psoriasis. Adv Exp Med Biol 1999; 455: 221-5.
2. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol 2000; 1: 159-65.
3. Tsankov N, Botev-Zlatkov N, Lazarova AZ et al. Psoriasis and drugs: influence of tetracyclines on the course of psoriasis. J Am Acad Dermatol 1988; 19: 629-32.
4. Wolf R, Schiavo AL, Lombardi ML, et al. The in vitro effect of hydroxychloroquine on skin morphology in psoriasis. Int J Dermatol 1999; 38: 154-7.
5. Ockenfels HM, Wagner SN, Keim-Maas C. et al. Lithium and psoriasis: Cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch Dermatol Res 1996; 288: 173-78.
6. Wolf R, D'Avino M, De Angelis F. et al. Effects of lithium carbonate (Li2CO3) on in-vitro-cultured normal human skin explants. J Eur Acad Dermatol Venereol 2000; 14: 97-9.
7. Cox NH, Gordon PM, Dodd H Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. Br J Dermatol 2002; 146: 1061-3.
8. Ascari-Raccagni A, Baldori U, Rossi E et al. Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy. J Eur Acad Dermatol Venereol 2000; 14: 315-16.
9. Adams B, Mutasim DF. Pustular eruption induced by olanzapine, a novel antipsychotic agent. J Am Acad Dermatol 1999; 41: 851-53.
10. Conley RR, Meltzer HY. Adverse events related to olanzapine. J Clin Psychiatry 2000; 61 Suppl 8: 26-30.
11. Lund BC, Perry PJ. Olanzapine: an atypical antipsychotic for schizophrenia. Expert Opin Pharmacother 2000; 1: 305-23.
12. Perkins DO, MC Clure RK. Hypersalivation coincident with olanzapine treatment. Am J Psychiatry 1998; 155: 993-4.
13. Niczyporuk W, Krajewska-kulak E, Zimnoch L. Preliminary study on the effect of the selected calmodulin antagonists on the skin. Rocz Akad Med Bialymst 1996; 41: 515-24.